Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Copper
Drug ID BADD_D00529
Description Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].
Indications and Usage For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB09130
KEGG ID Not Available
MeSH ID D003300
PubChem ID 23978
TTD Drug ID D01WMJ
NDC Product Code 68428-349; 82815-0001; 62106-5020; 51285-204; 0220-1623; 0220-1635; 59365-5128; 68428-140; 64117-958; 0220-1636
UNII 789U1901C5
Synonyms Copper | Copper-63 | Copper 63
Chemical Information
Molecular Formula Cu
CAS Registry Number 7440-50-8
SMILES [Cu]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Parosmia22.04.03.007; 17.04.04.002-Not Available
Pelvic pain21.10.01.001; 20.02.03.007; 07.01.06.012-
Polycystic ovaries21.11.01.006; 05.05.01.014-Not Available
Polymenorrhoea21.01.03.003-Not Available
Pregnancy18.08.02.004--Not Available
Premenstrual syndrome17.14.01.019; 21.01.01.007; 19.04.02.009-Not Available
Presyncope17.02.05.009; 02.11.04.013; 24.06.02.010-
Screaming08.01.03.099; 19.04.02.020-Not Available
Tenderness08.01.08.005-Not Available
Umbilical hernia07.16.03.001-Not Available
Urticaria23.04.02.001; 10.01.06.001--
Uterine disorder21.07.01.006-Not Available
Uterine enlargement21.07.01.007-Not Available
Uterine haemorrhage24.07.03.004; 21.07.01.005-
Uterine inflammation21.14.01.001-Not Available
Uterine leiomyoma21.07.02.004; 16.04.02.001-Not Available
Uterine pain21.07.01.008-
Uterine polyp21.07.02.001; 16.04.02.002-Not Available
Uterine prolapse21.07.05.006-Not Available
Uterine spasm21.07.03.002-Not Available
Vaginal discharge21.08.02.002-
Vaginal haemorrhage24.07.03.005; 21.08.01.001-
Vaginal infection21.14.02.002; 11.01.10.002--
Vaginal odour21.08.02.008-Not Available
Vulval disorder21.08.01.007-Not Available
Vulvovaginal discomfort21.08.02.005-Not Available
Uterine cyst16.04.02.003; 21.07.02.007-Not Available
Emotional distress19.04.02.008-Not Available
Fallopian tube cyst21.11.01.010; 16.04.01.004-Not Available
Suprapubic pain08.01.08.017-Not Available
The 3th Page    First    Pre   3 4 5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene